IPIC2023
IPIC2023 was a great success and a truly memorable experience, with nearly 900 participants from 70 countries coming together to advance primary immunodeficiencies (PIDs). Over the course of three days, attendees engaged in insightful discussions on PID diagnosis and clinical care, explored captivating poster presentations and enjoyed extensive networking opportunities.
We eagerly look forward to the next chapter at IPIC2025 in Prague.